Neuromuscular effect of pipecuronium bromide

dc.contributor.authorOzzeybek D.
dc.contributor.authorElar Z.
dc.contributor.authorCelebi G.
dc.contributor.authorTutan A.
dc.date.accessioned2019-10-27T00:33:42Z
dc.date.available2019-10-27T00:33:42Z
dc.date.issued1994
dc.departmentEge Üniversitesien_US
dc.description.abstract'Onset of action', 'duration of action', 'recovery index' and 'reversibility with anticholinesterases' of pipecuronium bromide, a new muscle relaxant, were studied on 24 cases with ASA physical status 1 who received thiopental, N2O-O2 and isoflurane anesthesia. Neuromuscular function was monitored with mechanomyography (MMG) and train-of-four (TOF) stimulation model of 3 groups each containing 8 patients; group I was given 70 µg.kg-1; group II 85 µg.kg-1 and group III 100 µg.kg-1 pipecuronium bromide. There was no statistically significant difference between 3 groups on the basis of 'onset of action' which was found to be 2.7 min; 2.8 min, 2.2 min in the groups I, II and III, respectively (p > 0.05). Statistically significant difference between groups on the basis of 'duration of action' which was found to be 73.3 min in the group I, 77.1 min in the group II and 104.8 min in the group III, was recognized to be due to the significantly longer action of the agent on 100 µg.kg-1 dose group (p < 0.01). 'Recovery index' and % T1 values before and 2, 5, 8 and 10 min after decurarization showed no statistically significant difference between groups (p > 0.05). TOF ratios before decurarization which were found to be 10.1% in the group I, 20.3% in the group II and 10.0% in the group III showed statistically significant difference between groups (p < 0.01). According to data obtained from this study, it was concluded that: by using the suggested doses for clinical practice, action of pipecuronium bromide, which started in 2-3 min and lasted 73-105 min, might be easily reversed by anticholinesterases (reversal time being dose dependent) and might be preferred for surgical procedures especially requiring long periods of muscle relaxation.en_US
dc.identifier.endpage28en_US
dc.identifier.issn1016-5150
dc.identifier.issn1016-5150en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage21en_US
dc.identifier.urihttps://hdl.handle.net/11454/24113
dc.identifier.volume22en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurk Anesteziyoloji ve Reanimasyonen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeuromuscular effecten_US
dc.subjectPipecuroniumen_US
dc.titleNeuromuscular effect of pipecuronium bromideen_US
dc.typeArticleen_US

Dosyalar